Long-Term Treatment and Effect of Discontinuation of Calcifediol in Postmenopausal Women with Vitamin D Deficiency: A Randomized Trial

Vitamin D plays a major role in bone health and probably also in multiple extraskeletal acute and chronic diseases. Although supplementation with calcifediol, a vitamin D metabolite, has demonstrated efficacy and safety in short-term clinical trials, its effects after long-term monthly administratio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JOURNAL OF BONE AND MINERAL RESEARCH 2023-04, Vol.38 (4), p.471-479
Hauptverfasser: Perez-Castrillon, Jose Luis, Duenas-Laita, Antonio, Gomez-Alonso, Carlos, Jodar, Esteban, del Pino-Montes, Javier, Brandi, Maria Luisa, Cereto Castro, Fernando, Quesada-Gomez, Jose Manuel, Gallego Lopez, Laura, Martinez, Jose Manuel Olmos, Exposito, Maria Rosa Alhambra, Galarraga, Bernat, Gonzalez-Macias, Jesus, Neyro, Jose Luis, Bouillon, Roger, Hernandez-Herrero, Gonzalo, Fernandez-Hernando, Nieves, Chinchilla, Sandra P
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 479
container_issue 4
container_start_page 471
container_title JOURNAL OF BONE AND MINERAL RESEARCH
container_volume 38
creator Perez-Castrillon, Jose Luis
Duenas-Laita, Antonio
Gomez-Alonso, Carlos
Jodar, Esteban
del Pino-Montes, Javier
Brandi, Maria Luisa
Cereto Castro, Fernando
Quesada-Gomez, Jose Manuel
Gallego Lopez, Laura
Martinez, Jose Manuel Olmos
Exposito, Maria Rosa Alhambra
Galarraga, Bernat
Gonzalez-Macias, Jesus
Neyro, Jose Luis
Bouillon, Roger
Hernandez-Herrero, Gonzalo
Fernandez-Hernando, Nieves
Chinchilla, Sandra P
description Vitamin D plays a major role in bone health and probably also in multiple extraskeletal acute and chronic diseases. Although supplementation with calcifediol, a vitamin D metabolite, has demonstrated efficacy and safety in short-term clinical trials, its effects after long-term monthly administration have been studied less extensively. This report describes the results of a 1-year, phase III-IV, double-blind, randomized, controlled, parallel, multicenter superiority clinical trial to assess the efficacy and safety of monthly calcifediol 0.266 mg versus cholecalciferol 25,000 IU (0.625 mg) in postmenopausal women with vitamin D deficiency (25(OH)D 
format Article
fullrecord <record><control><sourceid>kuleuven</sourceid><recordid>TN_cdi_kuleuven_dspace_20_500_12942_713143</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20_500_12942_713143</sourcerecordid><originalsourceid>FETCH-kuleuven_dspace_20_500_12942_7131433</originalsourceid><addsrcrecordid>eNqVjU1OwzAQhb0AiQK9w6yRgpw4DYUdaopYsEAooktr5IxhwLGresLfATg3qcQBYPX0nr6n70DN9HJZF7o25ZE6zvlFa90smmamvu9SfCo62g3Q7QhloCiAsYe19-QEkoeWs0tROI4onOJ-WmFw7KnnFIAj3Ke8P6YtjhkDbNJU4J3lGR5ZcJiIFlry7Jii-7yCa3iYFGngL-onLWM4VYceQ6b5b56os5t1t7otXsdA4xtF2-ctOrKVtgutbVld1pW9KE1ZG_NP-PzPsJUPMT8hQGK-</addsrcrecordid><sourcetype>Institutional Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Long-Term Treatment and Effect of Discontinuation of Calcifediol in Postmenopausal Women with Vitamin D Deficiency: A Randomized Trial</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Lirias (KU Leuven Association)</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Perez-Castrillon, Jose Luis ; Duenas-Laita, Antonio ; Gomez-Alonso, Carlos ; Jodar, Esteban ; del Pino-Montes, Javier ; Brandi, Maria Luisa ; Cereto Castro, Fernando ; Quesada-Gomez, Jose Manuel ; Gallego Lopez, Laura ; Martinez, Jose Manuel Olmos ; Exposito, Maria Rosa Alhambra ; Galarraga, Bernat ; Gonzalez-Macias, Jesus ; Neyro, Jose Luis ; Bouillon, Roger ; Hernandez-Herrero, Gonzalo ; Fernandez-Hernando, Nieves ; Chinchilla, Sandra P</creator><creatorcontrib>Perez-Castrillon, Jose Luis ; Duenas-Laita, Antonio ; Gomez-Alonso, Carlos ; Jodar, Esteban ; del Pino-Montes, Javier ; Brandi, Maria Luisa ; Cereto Castro, Fernando ; Quesada-Gomez, Jose Manuel ; Gallego Lopez, Laura ; Martinez, Jose Manuel Olmos ; Exposito, Maria Rosa Alhambra ; Galarraga, Bernat ; Gonzalez-Macias, Jesus ; Neyro, Jose Luis ; Bouillon, Roger ; Hernandez-Herrero, Gonzalo ; Fernandez-Hernando, Nieves ; Chinchilla, Sandra P</creatorcontrib><description>Vitamin D plays a major role in bone health and probably also in multiple extraskeletal acute and chronic diseases. Although supplementation with calcifediol, a vitamin D metabolite, has demonstrated efficacy and safety in short-term clinical trials, its effects after long-term monthly administration have been studied less extensively. This report describes the results of a 1-year, phase III-IV, double-blind, randomized, controlled, parallel, multicenter superiority clinical trial to assess the efficacy and safety of monthly calcifediol 0.266 mg versus cholecalciferol 25,000 IU (0.625 mg) in postmenopausal women with vitamin D deficiency (25(OH)D &lt; 20 ng/mL). A total of 303 women were randomized and 298 evaluated. Patients were randomized 1:1:1 to calcifediol 0.266 mg/month for 12 months (Group A1), calcifediol 0.266 mg/month for 4 months followed by placebo for 8 months (Group A2), and cholecalciferol 25,000 IU/month (0.625 mg/month) for 12 months (Group B). By month 4, stable 25(OH)D levels were documented with both calcifediol and cholecalciferol (intention-to-treat population): 26.8 ± 8.5 ng/mL (Group A1) and 23.1 ± 5.4 ng/mL (Group B). By month 12, 25(OH)D levels were 23.9 ± 8.0 ng/mL (Group A1) and 22.4 ± 5.5 ng/mL (Group B). When calcifediol treatment was withdrawn in Group A2, 25(OH)D levels decreased to baseline levels (28.5 ± 8.7 ng/mL at month 4 versus 14.4 ± 6.0 ng/mL at month 12). No relevant treatment-related safety issues were reported in any of the groups. The results confirm that long-term treatment with monthly calcifediol in vitamin D-deficient patients is effective and safe. The withdrawal of treatment leads to a pronounced decrease of 25(OH)D levels. Calcifediol presented a faster onset of action compared to monthly cholecalciferol. Long-term treatment produces stable and sustained 25(OH)D concentrations with no associated safety concerns. © 2023 Faes Farma SA. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).</description><identifier>ISSN: 0884-0431</identifier><language>eng</language><publisher>OXFORD UNIV PRESS</publisher><ispartof>JOURNAL OF BONE AND MINERAL RESEARCH, 2023-04, Vol.38 (4), p.471-479</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,315,776,780,27837</link.rule.ids></links><search><creatorcontrib>Perez-Castrillon, Jose Luis</creatorcontrib><creatorcontrib>Duenas-Laita, Antonio</creatorcontrib><creatorcontrib>Gomez-Alonso, Carlos</creatorcontrib><creatorcontrib>Jodar, Esteban</creatorcontrib><creatorcontrib>del Pino-Montes, Javier</creatorcontrib><creatorcontrib>Brandi, Maria Luisa</creatorcontrib><creatorcontrib>Cereto Castro, Fernando</creatorcontrib><creatorcontrib>Quesada-Gomez, Jose Manuel</creatorcontrib><creatorcontrib>Gallego Lopez, Laura</creatorcontrib><creatorcontrib>Martinez, Jose Manuel Olmos</creatorcontrib><creatorcontrib>Exposito, Maria Rosa Alhambra</creatorcontrib><creatorcontrib>Galarraga, Bernat</creatorcontrib><creatorcontrib>Gonzalez-Macias, Jesus</creatorcontrib><creatorcontrib>Neyro, Jose Luis</creatorcontrib><creatorcontrib>Bouillon, Roger</creatorcontrib><creatorcontrib>Hernandez-Herrero, Gonzalo</creatorcontrib><creatorcontrib>Fernandez-Hernando, Nieves</creatorcontrib><creatorcontrib>Chinchilla, Sandra P</creatorcontrib><title>Long-Term Treatment and Effect of Discontinuation of Calcifediol in Postmenopausal Women with Vitamin D Deficiency: A Randomized Trial</title><title>JOURNAL OF BONE AND MINERAL RESEARCH</title><description>Vitamin D plays a major role in bone health and probably also in multiple extraskeletal acute and chronic diseases. Although supplementation with calcifediol, a vitamin D metabolite, has demonstrated efficacy and safety in short-term clinical trials, its effects after long-term monthly administration have been studied less extensively. This report describes the results of a 1-year, phase III-IV, double-blind, randomized, controlled, parallel, multicenter superiority clinical trial to assess the efficacy and safety of monthly calcifediol 0.266 mg versus cholecalciferol 25,000 IU (0.625 mg) in postmenopausal women with vitamin D deficiency (25(OH)D &lt; 20 ng/mL). A total of 303 women were randomized and 298 evaluated. Patients were randomized 1:1:1 to calcifediol 0.266 mg/month for 12 months (Group A1), calcifediol 0.266 mg/month for 4 months followed by placebo for 8 months (Group A2), and cholecalciferol 25,000 IU/month (0.625 mg/month) for 12 months (Group B). By month 4, stable 25(OH)D levels were documented with both calcifediol and cholecalciferol (intention-to-treat population): 26.8 ± 8.5 ng/mL (Group A1) and 23.1 ± 5.4 ng/mL (Group B). By month 12, 25(OH)D levels were 23.9 ± 8.0 ng/mL (Group A1) and 22.4 ± 5.5 ng/mL (Group B). When calcifediol treatment was withdrawn in Group A2, 25(OH)D levels decreased to baseline levels (28.5 ± 8.7 ng/mL at month 4 versus 14.4 ± 6.0 ng/mL at month 12). No relevant treatment-related safety issues were reported in any of the groups. The results confirm that long-term treatment with monthly calcifediol in vitamin D-deficient patients is effective and safe. The withdrawal of treatment leads to a pronounced decrease of 25(OH)D levels. Calcifediol presented a faster onset of action compared to monthly cholecalciferol. Long-term treatment produces stable and sustained 25(OH)D concentrations with no associated safety concerns. © 2023 Faes Farma SA. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).</description><issn>0884-0431</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>FZOIL</sourceid><recordid>eNqVjU1OwzAQhb0AiQK9w6yRgpw4DYUdaopYsEAooktr5IxhwLGresLfATg3qcQBYPX0nr6n70DN9HJZF7o25ZE6zvlFa90smmamvu9SfCo62g3Q7QhloCiAsYe19-QEkoeWs0tROI4onOJ-WmFw7KnnFIAj3Ke8P6YtjhkDbNJU4J3lGR5ZcJiIFlry7Jii-7yCa3iYFGngL-onLWM4VYceQ6b5b56os5t1t7otXsdA4xtF2-ctOrKVtgutbVld1pW9KE1ZG_NP-PzPsJUPMT8hQGK-</recordid><startdate>202304</startdate><enddate>202304</enddate><creator>Perez-Castrillon, Jose Luis</creator><creator>Duenas-Laita, Antonio</creator><creator>Gomez-Alonso, Carlos</creator><creator>Jodar, Esteban</creator><creator>del Pino-Montes, Javier</creator><creator>Brandi, Maria Luisa</creator><creator>Cereto Castro, Fernando</creator><creator>Quesada-Gomez, Jose Manuel</creator><creator>Gallego Lopez, Laura</creator><creator>Martinez, Jose Manuel Olmos</creator><creator>Exposito, Maria Rosa Alhambra</creator><creator>Galarraga, Bernat</creator><creator>Gonzalez-Macias, Jesus</creator><creator>Neyro, Jose Luis</creator><creator>Bouillon, Roger</creator><creator>Hernandez-Herrero, Gonzalo</creator><creator>Fernandez-Hernando, Nieves</creator><creator>Chinchilla, Sandra P</creator><general>OXFORD UNIV PRESS</general><scope>FZOIL</scope></search><sort><creationdate>202304</creationdate><title>Long-Term Treatment and Effect of Discontinuation of Calcifediol in Postmenopausal Women with Vitamin D Deficiency: A Randomized Trial</title><author>Perez-Castrillon, Jose Luis ; Duenas-Laita, Antonio ; Gomez-Alonso, Carlos ; Jodar, Esteban ; del Pino-Montes, Javier ; Brandi, Maria Luisa ; Cereto Castro, Fernando ; Quesada-Gomez, Jose Manuel ; Gallego Lopez, Laura ; Martinez, Jose Manuel Olmos ; Exposito, Maria Rosa Alhambra ; Galarraga, Bernat ; Gonzalez-Macias, Jesus ; Neyro, Jose Luis ; Bouillon, Roger ; Hernandez-Herrero, Gonzalo ; Fernandez-Hernando, Nieves ; Chinchilla, Sandra P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-kuleuven_dspace_20_500_12942_7131433</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Perez-Castrillon, Jose Luis</creatorcontrib><creatorcontrib>Duenas-Laita, Antonio</creatorcontrib><creatorcontrib>Gomez-Alonso, Carlos</creatorcontrib><creatorcontrib>Jodar, Esteban</creatorcontrib><creatorcontrib>del Pino-Montes, Javier</creatorcontrib><creatorcontrib>Brandi, Maria Luisa</creatorcontrib><creatorcontrib>Cereto Castro, Fernando</creatorcontrib><creatorcontrib>Quesada-Gomez, Jose Manuel</creatorcontrib><creatorcontrib>Gallego Lopez, Laura</creatorcontrib><creatorcontrib>Martinez, Jose Manuel Olmos</creatorcontrib><creatorcontrib>Exposito, Maria Rosa Alhambra</creatorcontrib><creatorcontrib>Galarraga, Bernat</creatorcontrib><creatorcontrib>Gonzalez-Macias, Jesus</creatorcontrib><creatorcontrib>Neyro, Jose Luis</creatorcontrib><creatorcontrib>Bouillon, Roger</creatorcontrib><creatorcontrib>Hernandez-Herrero, Gonzalo</creatorcontrib><creatorcontrib>Fernandez-Hernando, Nieves</creatorcontrib><creatorcontrib>Chinchilla, Sandra P</creatorcontrib><collection>Lirias (KU Leuven Association)</collection><jtitle>JOURNAL OF BONE AND MINERAL RESEARCH</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Perez-Castrillon, Jose Luis</au><au>Duenas-Laita, Antonio</au><au>Gomez-Alonso, Carlos</au><au>Jodar, Esteban</au><au>del Pino-Montes, Javier</au><au>Brandi, Maria Luisa</au><au>Cereto Castro, Fernando</au><au>Quesada-Gomez, Jose Manuel</au><au>Gallego Lopez, Laura</au><au>Martinez, Jose Manuel Olmos</au><au>Exposito, Maria Rosa Alhambra</au><au>Galarraga, Bernat</au><au>Gonzalez-Macias, Jesus</au><au>Neyro, Jose Luis</au><au>Bouillon, Roger</au><au>Hernandez-Herrero, Gonzalo</au><au>Fernandez-Hernando, Nieves</au><au>Chinchilla, Sandra P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long-Term Treatment and Effect of Discontinuation of Calcifediol in Postmenopausal Women with Vitamin D Deficiency: A Randomized Trial</atitle><jtitle>JOURNAL OF BONE AND MINERAL RESEARCH</jtitle><date>2023-04</date><risdate>2023</risdate><volume>38</volume><issue>4</issue><spage>471</spage><epage>479</epage><pages>471-479</pages><issn>0884-0431</issn><abstract>Vitamin D plays a major role in bone health and probably also in multiple extraskeletal acute and chronic diseases. Although supplementation with calcifediol, a vitamin D metabolite, has demonstrated efficacy and safety in short-term clinical trials, its effects after long-term monthly administration have been studied less extensively. This report describes the results of a 1-year, phase III-IV, double-blind, randomized, controlled, parallel, multicenter superiority clinical trial to assess the efficacy and safety of monthly calcifediol 0.266 mg versus cholecalciferol 25,000 IU (0.625 mg) in postmenopausal women with vitamin D deficiency (25(OH)D &lt; 20 ng/mL). A total of 303 women were randomized and 298 evaluated. Patients were randomized 1:1:1 to calcifediol 0.266 mg/month for 12 months (Group A1), calcifediol 0.266 mg/month for 4 months followed by placebo for 8 months (Group A2), and cholecalciferol 25,000 IU/month (0.625 mg/month) for 12 months (Group B). By month 4, stable 25(OH)D levels were documented with both calcifediol and cholecalciferol (intention-to-treat population): 26.8 ± 8.5 ng/mL (Group A1) and 23.1 ± 5.4 ng/mL (Group B). By month 12, 25(OH)D levels were 23.9 ± 8.0 ng/mL (Group A1) and 22.4 ± 5.5 ng/mL (Group B). When calcifediol treatment was withdrawn in Group A2, 25(OH)D levels decreased to baseline levels (28.5 ± 8.7 ng/mL at month 4 versus 14.4 ± 6.0 ng/mL at month 12). No relevant treatment-related safety issues were reported in any of the groups. The results confirm that long-term treatment with monthly calcifediol in vitamin D-deficient patients is effective and safe. The withdrawal of treatment leads to a pronounced decrease of 25(OH)D levels. Calcifediol presented a faster onset of action compared to monthly cholecalciferol. Long-term treatment produces stable and sustained 25(OH)D concentrations with no associated safety concerns. © 2023 Faes Farma SA. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).</abstract><pub>OXFORD UNIV PRESS</pub><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0884-0431
ispartof JOURNAL OF BONE AND MINERAL RESEARCH, 2023-04, Vol.38 (4), p.471-479
issn 0884-0431
language eng
recordid cdi_kuleuven_dspace_20_500_12942_713143
source Oxford University Press Journals All Titles (1996-Current); Lirias (KU Leuven Association); Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
title Long-Term Treatment and Effect of Discontinuation of Calcifediol in Postmenopausal Women with Vitamin D Deficiency: A Randomized Trial
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T06%3A03%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-kuleuven&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long-Term%20Treatment%20and%20Effect%20of%20Discontinuation%20of%20Calcifediol%20in%20Postmenopausal%20Women%20with%20Vitamin%20D%20Deficiency:%20A%20Randomized%20Trial&rft.jtitle=JOURNAL%20OF%20BONE%20AND%20MINERAL%20RESEARCH&rft.au=Perez-Castrillon,%20Jose%20Luis&rft.date=2023-04&rft.volume=38&rft.issue=4&rft.spage=471&rft.epage=479&rft.pages=471-479&rft.issn=0884-0431&rft_id=info:doi/&rft_dat=%3Ckuleuven%3E20_500_12942_713143%3C/kuleuven%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true